AVIR
Atea Pharmaceuticals (AVIR)
$51
About Atea Pharmaceuticals (AVIR)
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
Details
Daily high
$4.54
Daily low
$4.37
Price at open
$4.37
52 Week High
$6.45
52 Week Low
$2.78
Market cap
351.3M
Dividend yield
0.00%
Volume
18,096
Avg. volume
287,718
P/E ratio
-2.07
Atea Pharmaceuticals News
Details
Daily high
$4.54
Daily low
$4.37
Price at open
$4.37
52 Week High
$6.45
52 Week Low
$2.78
Market cap
351.3M
Dividend yield
0.00%
Volume
18,096
Avg. volume
287,718
P/E ratio
-2.07